Nice one again, Torpy
I also subscribe to Drug Patent Watch to get a feel of the legal challenges in the field - and for over a year I've gotten a feel for it. As a result, I've come to the conclusion Paradigm's patents are as strong as anyone else's (new or repurposed a patent doesn't categorise, as long as you have a new invention) but not at all be surprised if there is a legal challenge. It happens all the time in this field.
Nice one again, TorpyI also subscribe to Drug Patent Watch to...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.025(10.9%) |
Mkt cap ! $85.70M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 28.0¢ | 24.0¢ | $260.9K | 1.047M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 28806 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 39899 | 4 |
View Market Depth
| Last trade - 12.59pm 20/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |